South Korean shipping stocks weaken on tariff worries

South Korean shipping stocks fell on Tuesday as investors fretted over a prolonged global trade slowdown tied to...

Consignment of 200,000 Amphotericin B doses used in black...

New Delhi [India], May 30 (ANI): A consignment of 200,000 AmBisome (Amphotericin B injection), used in black...

COVID-19: Another 29,021 vials of Remdesivir sent by Gilead...

Mumbai (Maharashtra) [India], May 15 (ANI): American pharmaceutical company Gilead Sciences sent another 29,021...

Third consignment of 25000 doses of Remdesivir from Gilead...

New Delhi [India], May 8 (ANI): The third consignment consisting of 25000 doses of Remdesivir from American...

Gilead Sciences gifts another 25,600 vials of Remdesivir to India

New Delhi [India], May 8 (ANI): India thanked American biopharmaceutical company Gilead Sciences on Saturday for...

Gilead to give licensees in India support to open more...

California [US], April 29 (ANI/Sputnik): US-based Gilead Sciences Inc company, the developer of antiviral drug...

US FDA approves remdesivir, first drug to treat COVID-19 patients

Washington [US], October 23 (ANI): The United States Food and Drug Administration (FDA) has approved Remdesivir for...

Dr Reddy's launches Redyx (Remdesivir) in India for COVID-19...

Hyderabad (Telangana) [India], September 9 (ANI): Dr Reddy's Laboratories on Wednesday announced the launch of...

At Rs 2,800, Zydus launches Remdac for treatment of COVID-19...

Ahmedabad (Gujarat) [India], Aug 13 (ANI): Pharmaceutical major Zydus Cadila said on Thursday it has launched...

Jubilant launches Remdesivir in India for treatment of COVID-19

Noida (Uttar Pradesh) [India], Aug 4 (ANI): Jubilant Life Sciences has launched Remdesivir for injection under the...

Mylan gets DCGI nod for remdesivir in India, to launch at Rs...

Bengaluru (Karnataka) [India], July 7 (ANI): Global pharmaceutical major Mylan has got approval for its remdesivir...

Gilead Sciences to start trials of inhaled version of remdesivir

California [USA], June 23 (ANI): US-based biopharmaceutical major Gilead Sciences will soon start clinical trials...